Company intelligence
Adcendo
Developing innovative ADC cancer therapies through precision science and design.
Biotechnology Research
Frederiksberg, DK
67 employees
Founded 2017
2 public signals
About Adcendo
Adcendo is a global clinical-stage biotech company dedicated to developing transformative first- and potential best-in-class antibody-drug conjugate (ADC) therapies targeting cancers with high unmet medical need. Led by a team of experienced biopharma executives with a track record of advancing multiple ADCs to approval, Adcendo integrates novel targets, optimized linker-payload combinations, and a rationally designed development strategy to drive next-generation cancer therapies. Designed for Precision. Developed for Life. Read more at www.adcendo.com
Verified activity
Signals from Adcendo
2 published signals